Long, G. V., Dalle, S., Tawbi, H. A., Jalkanen, K. J., Ascierto, P. A., Dummer, R., Wilgenhof, S., Lorigan, P., Dreno, B., Hill, A. G., Lipson, E. J., Larkin, J., Martens, U. M., Couselo, E. M., Strauss, J., Wolf, D., Mukherjee, S., Dolfi, S., Suryawanshi, S., Gaudy-Marqueste, C. (2025). Randomized dose evaluation of nivolumab + relatlimab (NIVO + RELA) in patients (pts) with advanced melanoma: Results from RELATIVITY-020.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.9526